Tripegfilgrastim Trial to Reduce the Risk of Severe Neutropenia in Patients With Unresectable Pancreaticobiliary Cancers

NCT06135896 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

98

Enrollment

OTHER_GOV

Sponsor class

Conditions

Unresectable Pancreatic Cancer
Unresectable Bile Duct Carcinoma
Unresectable Biliary Tract Carcinoma

Interventions

DRUG: Tripegfilgrastim

Sponsor

National Cancer Center, Korea

Collaborators

[object Object]